A Dose-Escalating Phase I of Imatinib Mesylate With Fixed Dose of Metronomic Cyclophosphamide in Targeted Olid Tumours
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.648
Full Text
Open PDFAbstract
Available in full text
Date
October 22, 2013
Authors
Publisher
Springer Science and Business Media LLC